Center for Breakthrough Medicines launches analytical testing services The Center for Breakthrough Medicines (CBM) announced the opening of its analytical testing services laboratories. CBM's services will support custom assay development, characterization, and release for cell and gene therapy products, as well as for biologics, vaccines, and plasmids.Read More
Agilent acquires AI technology to enhance lab productivity Agilent Technologies has acquired advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine-learning software developer that creates innovative analysis solutions in lab testing. Agilent will integrate the software, known as ACIES, into its gas chromatography and mass spectrometry platforms to improve the productivity, efficiency, and accuracy of high-throughput labs the company serves around the world.Read More
Walking Fish Therapeutics closes $73M series A financing round Walking Fish Therapeutics has completed an oversubscribed series A financing round, raising a total of $73 million. The proceeds will accelerate platform development and further establish Walking Fish in the rapidly emerging B-cell therapeutics field, the firm said.Read More
IMIDomics announces strategic investment Evotec has made an equity investment in IMIDomics. In conjunction with the investment, an Evotec representative will join IMIDomics' board of directors.Read More
Terray Therapeutics launches AI-driven small molecule drug discovery Terray Therapeutics has closed $60 million in series A financing to advance its novel tNova platform. The financing will be used to advance the company's preclinical pipeline of therapeutics and the company's discovery partnerships.Read More